Financial Summary (All financials)
In millions, except per share items | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 |
Revenues | 27.5 | 26.3 | 25.8 | 23.0 | 20.7 | 20.3 | 26.4 | 26.6 |
Revenue growth | 4.3% | 2.1% | 12.4% | 10.7% | 2.0% | -22.9% | -0.7% | 24.3% |
Cost of goods sold | 17.9 | 18.4 | 16.9 | 17.1 | 15.2 | 14.3 | 15.6 | 14.8 |
Gross profit | 9.6 | 7.9 | 8.9 | 5.8 | 5.5 | 6.0 | 10.8 | 11.8 |
Gross margin | 34.8% | 30.0% | 34.3% | 25.5% | 26.6% | 29.7% | 41.0% | 44.3% |
Sales and marketing | 3.8 | 3.6 | 4.2 | 4.2 | 4.0 | 3.9 | 5.0 | 4.6 |
Research and development | | | 1.1 | 1.4 | 1.4 | 1.3 | 2.1 | 2.7 |
General and administrative | 4.1 | 3.0 | 3.0 | 3.3 | 3.5 | 3.4 | 4.1 | 3.6 |
EBIT | 0.6 | 0.0 | 0.6 | -3.0 | -3.3 | -2.4 | -0.3 | 0.9 |
EBIT margin | 2.3% | 0.1% | 2.2% | -13.0% | -15.7% | -11.8% | -1.3% | 3.4% |
Pre-tax income | 0.7 | -0.3 | 0.4 | -4.7 | -3.2 | -2.9 | -0.3 | 0.9 |
Income taxes | 0.0 | -0.3 | 0.0 | -0.3 | 0.1 | 0.1 | -0.1 | 0.3 |
Tax rate | 3.2% | 108.3% | 8.3% | 6.6% | | | 26.1% | 28.6% |
Net income | -0.1 | -0.4 | -0.1 | -4.9 | -3.8 | -3.0 | -0.2 | 0.7 |
Net margin | -0.5% | -1.5% | -0.3% | -21.2% | -18.6% | -14.7% | -0.9% | 2.5% |
|
Diluted EPS | ($0.04) | ($0.11) | ($0.03) | ($1.36) | ($1.07) | ($0.83) | ($66.59) | $0.19 |
Shares outstanding (diluted) | 3.6 | 3.6 | 3.6 | 3.6 | 3.6 | 3.6 | 0.0 | 3.6 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|